Wikipedia:Articles for deletion/Roxadustat


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was delete. Kudpung กุดผึ้ง (talk) 13:22, 21 June 2015 (UTC)

Roxadustat

 * – ( View AfD View log  Stats )

No assertion of notability. Not enough coverage in reliable sources or medical reliable sources to verify or sustian article. Fails general notability guidelines J bh  Talk  17:04, 14 June 2015 (UTC)
 * Note: This debate has been included in the list of Medicine-related deletion discussions. • Gene93k (talk) 21:01, 14 June 2015 (UTC)


 * Weak delete: Because the article is about a drug in phase III trials, it needs to pass a world of different hurdles for notability than if it were simply a compound or substance under investigation. I.e. it is arguably in a marketable form and therefore is in a position of being a commercial product rather than a scientific finding. Because of that, it needs testimony to notability, and contributor expertise becomes potential COI. However, in general I think it's probably good that people working on basic research are contributors. Hithladaeus (talk) 11:48, 15 June 2015 (UTC)
 * weak delete per hithladaeus. Gaijin42 (talk) 19:52, 15 June 2015 (UTC)


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.